Cargando…

Safety and Adverse Events Among Long-term Care Residents Receiving a Third COVID-19 mRNA Vaccine Booster Dose in Quebec

This cohort study examines the safety and adverse events associated with receipt of various 3-dose combinations of COVID-19 mRNA vaccines with among long-term care residents in Quebec, Canada.

Detalles Bibliográficos
Autores principales:	Zhang, Xi Sophie, Moreau, Andréanne, Cruz-Santiago, Diana, Langevin, Stéphanie, Nguyen, Quoc Dinh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2022
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305376/ https://www.ncbi.nlm.nih.gov/pubmed/35862047 http://dx.doi.org/10.1001/jamanetworkopen.2022.23401

Ejemplares similares

Surveillance of Adverse Events Following Immunization (AEFI) after Third Dose Booster Vaccination with mRNA-Based Vaccine in Universitas Indonesia Hospital Health Personnel
por: Hidayat, Rakhmad, et al.
Publicado: (2022)

Frequency and Nuisance Level of Adverse Events in Individuals Receiving Homologous and Heterologous COVID-19 Booster Vaccine
por: Rzymski, Piotr, et al.
Publicado: (2022)

The association between adverse events of COVID-19 vaccination and anxiety and willingness to receive a booster dose
por: Chen, Liling, et al.
Publicado: (2023)

Ontario, Quebec and Alberta lead record family medicine residency vacancies
por: Duong, Diana, et al.
Publicado: (2023)

Severe Acute Myocarditis after the Third (Booster) Dose of mRNA COVID-19 Vaccination
por: Mengesha, Bethlehem, et al.
Publicado: (2022)

Towards Feasible Solutions for Load Monitoring in Quebec Residences †
por: Hosseini, Sayed Saeed, et al.
Publicado: (2023)

1612P Immunogenicity of two doses of inactive COVID-19 vaccine and third booster dose mRNA vaccine in patients with cancer receiving active systemic therapy
por: Guven, D.C.C., et al.
Publicado: (2022)

Immunogenicity and Safety of the Third Booster Dose with mRNA-1273 COVID-19 Vaccine after Receiving Two Doses of Inactivated or Viral Vector COVID-19 Vaccine
por: Tangsathapornpong, Auchara, et al.
Publicado: (2023)

Are Residents' Extended Shifts Associated With Adverse Events?
por: Szklo-Coxe, Mariana
Publicado: (2006)

Booster Effect of a Third mRNA-Based COVID-19 Vaccine Dose in Patients with Myeloid Malignancies
por: Mori, Akio, et al.
Publicado: (2022)

Booster effect of a third mRNA‐based COVID‐19 vaccine dose in patients with myeloid malignancies
por: Mori, Akio, et al.
Publicado: (2023)

Common Adverse Events from Mixing COVID-19 Vaccine Booster in Hanoi, Vietnam
por: Hung, Pham Van, et al.
Publicado: (2023)

Spontaneously reported adverse events following COVID-19 basic and booster immunizations in the Netherlands
por: van der Boor, Saskia C., et al.
Publicado: (2023)

Adverse events following mRNA SARS-CoV-2 vaccination among U.S. nursing home residents
por: Bardenheier, Barbara H., et al.
Publicado: (2021)

Profiles of teacher–child interaction quality in groups of 3-year-old children in Quebec and France
por: Roy-Vallières, Maude, et al.
Publicado: (2021)

Booster effect of the third dose of SARS-CoV-2 mRNA vaccine in Japanese kidney transplant recipients
por: Kawabe, Mayuko, et al.
Publicado: (2023)

Immunogenicity after a Third COVID-19 mRNA Booster in Solid Cancer Patients Who Previously Received the Primary Heterologous CoronaVac/ChAdOx1 Vaccine
por: Luangdilok, Sutima, et al.
Publicado: (2022)

Campylobacteriosis, Eastern Townships, Québec
por: Michaud, Sophie, et al.
Publicado: (2004)

Prognosis tools for short-term adverse events in older emergency department users: result of a Québec observational prospective cohort
por: Launay, Cyrille P., et al.
Publicado: (2021)

Wait Times and Survival in Lung Cancer Patients across the Province of Quebec, Canada
por: Denault, Marie-Hélène, et al.
Publicado: (2022)

Self-Reported and Physiologic Reactions to Third BNT162b2 mRNA COVID-19 (Booster) Vaccine Dose
por: Mofaz, Merav, et al.
Publicado: (2022)

Antibody response to third and fourth BNT162b2 mRNA booster vaccinations in healthcare workers in Tokyo, Japan
por: Sanada, Takahiro, et al.
Publicado: (2023)

Adverse events of a third dose of BNT162b2 mRNA COVID-19 vaccine among Korean healthcare workers
por: Lee, Dong Yeop, et al.
Publicado: (2023)

Native American Admixture in the Quebec Founder Population
por: Moreau, Claudia, et al.
Publicado: (2013)

Posterior Reversible Encephalopathy Syndrome Onset Within 24 Hours Following Moderna mRNA Booster COVID-19 Vaccination: Vaccine Adverse Event Vs. Hypertension?
por: McCullough, Jocelyn, et al.
Publicado: (2022)

Antibody Responses to Third-Dose mRNA Vaccines in Nursing Home and Assisted Living Residents
por: Zhang, Ali, et al.
Publicado: (2022)

Effectiveness of Second mRNA COVID-19 Booster Vaccine in Immunocompromised Persons and Long-Term Care Facility Residents
por: Kim, Yoo-Yeon, et al.
Publicado: (2022)

Interventions in health organisations to reduce the impact of adverse events in second and third victims
por: Mira, José Joaquín, et al.
Publicado: (2015)

IgG level of the third booster dose for mRNA of SARS-CoV-2 vaccines among Iraqi healthcare workers
por: Rasheed, Waleed S., et al.
Publicado: (2023)

Québec 2002 /
Publicado: (2001)

Québec : état et société
Publicado: (1994)

Emerging Adults’ Adverse Life Events and Psychological Functioning: A Comparison Based on Intergenerational Trajectories of Child Maltreatment
por: Langevin, Rachel, et al.
Publicado: (2022)

Booster dose of COVID-19 mRNA vaccine does not increase risks of myocarditis and pericarditis compared with primary vaccination: New insights from the vaccine adverse event reporting system
por: Chen, Congqin, et al.
Publicado: (2022)

Short-term Adverse Events After the Third Dose of the BNT162b2 mRNA COVID-19 Vaccine in Adults 60 Years or Older
por: Auster, Oren, et al.
Publicado: (2022)

Investigation of Adverse Events Experienced by Healthcare Workers following Immunization with Homologous or Heterologous COVID-19 Booster Vaccinations
por: Wei, Yunhua, et al.
Publicado: (2022)

Bivalent BNT162b2 mRNA original/omicron BA.4-5 booster vaccination: adverse reactions and inability to work compared with the monovalent COVID-19 booster
por: Wagenhäuser, Isabell, et al.
Publicado: (2023)

Measurement and Compensation of Second and Third Order Resonances at the CERN PS Booster
por: Urschütz, Peter
Publicado: (2004)

Measurement and Compensation of Second and Third Order Resonances at the CERN PS Booster
por: Urschütz, Peter
Publicado: (2004)

Third booster vaccination and stopping the Omicron, a new variant of concern
por: Ghazvini, Kiarash, et al.
Publicado: (2022)

Third booster vaccination and stopping the Omicron, a new variant of concern
por: Ghazvini, Kiarash, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ucjs5q8c6ige2fpi28did2dqcp